Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 11, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$14.6B
sum of reported positions
Reported positions
522
Changes vs prior quarter
505
102 new · 66 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 161 measured positions in 8 quarters, the typical new or larger position finished −2.3 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
TEVA PHARMACEUTICAL INDS LTD | 42.9M | $1.45B | 9.9% |
| 3.51M | $914M | 6.2% | |
SELECT SECTOR SPDR TR | 4.23M | $784M | 5.4% |
ISHARES TR | 4.01M | $579M | 4.0% |
| 1.16M | $553M | 3.8% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $10.5B | $14.6B |
| Positions | 486 | 522 |
| Biggest line | — | TEVA PHARMACEUTICAL INDS LTD 10% |
INVESCO EXCHANGE TRADED FD T |
| 2.31M |
| $491M |
| 3.4% |
| 2.31M | $461M | 3.2% |
| 1.46M | $349M | 2.4% |
| 618K | $335M | 2.3% |
VANGUARD SCOTTSDALE FDS | 3.04M | $323M | 2.2% |
ISHARES TR | 1.28M | $310M | 2.1% |
| 862K | $305M | 2.1% |
| 390K | $297M | 2.0% |
| 795K | $296M | 2.0% |
ISHARES TR | 2.68M | $264M | 1.8% |
| 751K | $256M | 1.7% |
| 646K | $244M | 1.7% |
ISHARES TR | 1.51M | $237M | 1.6% |
| 695K | $201M | 1.4% |
| 808K | $198M | 1.4% |
| 1.37M | $196M | 1.3% |
| 2.08M | $190M | 1.3% |
SELECT SECTOR SPDR TR | 988K | $188M | 1.3% |
| 5.37M | $187M | 1.3% |
ISHARES INC | 4.99M | $172M | 1.2% |
S&P Global (SPGI)
1,704 → 1,524 shares (−11%)
Carrier Global (CARR)
8,655 → 8,369 shares (−3%)
Cipher Digital (CIFR)
26K → 25K shares (−4%)
First Solar (FSLR)
3,471 → 2,342 shares (−33%)
Barrick Mining (B)
19K → 15K shares (−21%)
Idexx Laboratories (IDXX)
1,267 → 994 shares (−22%)
Harrow (HROW)
13K → 12K shares (−6%)
INVESCO EXCH TRD SLF IDX FD
26K → 25K shares (−2%)
Amkor Technology (AMKR)
9,978 → 5,803 shares (−42%)
Agnico Eagle Mines (AEM)
4,890 → 3,165 shares (−35%)
INNOVATOR ETFS TRUST
12K → 10K shares (−19%)
Viavi Solutions (VIAV)
12K → 9,927 shares (−19%)
Terawulf (WULF)
22K → 19K shares (−16%)
Franco Nevada (FNV)
33K → 32K shares (−1%)
Core Scientific, Inc. (CORZ)
23K → 18K shares (−22%)
EnerSys (ENS)
2,586 → 1,833 shares (−29%)
Waters Corporation (WAT)
1,995 → 1,059 shares (−47%)
Hut 8 (HUT)
5,801 → 3,350 shares (−42%)
Kimberly-Clark (KMB)
7,652 → 3,359 shares (−56%)
Robinhood Markets (HOOD)
3,754 → 3,556 shares (−5%)
SPDR SERIES TRUST
14K → 3,016 shares (−79%)
American Express (AXP)
2,152 → 1,030 shares (−52%)
ISHARES TR
50K → 4,209 shares (−92%)
INNOVATOR ETFS TRUST
8,055 → 6,765 shares (−16%)
INNOVATOR ETFS TRUST
14K → 11K shares (−22%)